Table 4 Differences in prediction of CVS and DCI in surgical and endovascular group in a multivariate logistic regression.

From: Use of thrombocyte count dynamics after aneurysmal subarachnoid hemorrhage to predict cerebral vasospasm and delayed cerebral ischemia: a retrospective monocentric cohort study

 

CVS prediction in

surgical cohort

CVS prediction in

endovascular cohort

DCI prediction in

surgical cohort

DCI prediction in

endovascular cohort

OR

95% CI

p-value

OR

95% CI

p-value

OR

95% CI

p-value

OR

95% CI

p-value

mFS

1

2

+

+

+

2.1

-2.45, 3.93

0.648

3.06

-0.79, 3.02

0.25

2.61

-1.95, 3.87

0.518

3

5.14

-0.18, 3.46

0.078

6.23

0.18, 3.48

0.030*

1.88

-0.87, 2.14

0.41

1.73

-1.11, 2.21

0.516

4

10.36

0.12, 4.56

0.039*

34.4

1.67, 5.41

< 0.001**

3.06

-0.47, 2.7

0.167

2.96

-0.58, 2.75

0.201

TC decrease [%]

≤ 12.6

> 12.6

15.81

1.45, 4.07

< 0.001**

10.9

1.33, 3.45

< 0.001**

3.36

0.17, 2.25

0.023*

2.5

0.06, 1.77

0.036*

  1. * p < 0.05; ** p < 0.001; +unrealistically high values measured, since all grade 2 mFS patients in surgical cohort developed CVS.
  2. CVS cerebral vasospasm, DCI delayed cerebral ischemia, mFS modified fisher scale, TC thrombocyte count, Hct hematocrit, CRP C-reactive-protein.